Huntsville Hospital
Approved Hospital Formulary
Suggestions or Corrections?
Above and Beyond Nominations
Formulary Request
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Formulary
Restricted
Non-formulary
Therapeutic Interchange
Black Box Warning
HAZ-MED
Chemotherapy
Formulary, Not Routinely Stocked
Patient Fact Sheets
Hormonal Therapy
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
News
Boards
Medications not yet evaluated by P&T are considered
NON-FORMULARY
. . . . . Always check 2 unique patient identifiers -
NAME
and
DATE OF BIRTH
- at every step! . . . . .
Please be sure to document all clinical activities daily.
Huntsville Hospital
Approved Hospital Formulary
Suggestions or Corrections?
Above and Beyond Nominations
Formulary Request
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Formulary
Restricted
Non-formulary
Therapeutic Interchange
Black Box Warning
HAZ-MED
Chemotherapy
Formulary, Not Routinely Stocked
Patient Fact Sheets
Hormonal Therapy
Webpage Links
Search results for:
raloxifene
raloxifene
Formulary
Drug Name
Form
Strength
Formulary Unrestricted
Formulary Restricted
Non-Formulary
Interchange
Evista
TABLET, ORAL
60 mg
VIEW MORE
Estrogen Agonists-Antagonists
CLASS
681612
Comments:
Evista medication guide
Last updated:
Oct. 4, 2023
Black Box Warning:
Risk of VTE and death from stroke
HAZ-MED:
Group 2
Hormonal Therapy:
This drug is a hormonal therapy in used in oncologic conditions. This drug may be resumed by a hospitalist or non-oncology healthcare provider without contacting an oncology pharmacy specialist or consulting an oncologist.
Micromedex
UpToDate
Lippincott Advisor
Evista medication guide